Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer
NCT ID: NCT00540280
Last Updated: 2011-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE3
10 participants
INTERVENTIONAL
2003-10-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer
NCT00329472
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
NCT00002852
Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer
NCT00313690
Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
NCT00113386
Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer
NCT00622349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgery alone
Surgery alone
Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin
Surgery + Chemo + RT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin
Surgery + Chemo + RT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Faisal Specialist Hospital & Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
King Faisal Specialist Hospital & Research Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khalid Rehman, MD
Role: PRINCIPAL_INVESTIGATOR
King Faisal Specialist Hospital & Research Centre, Saudi Arabia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAC#2031-059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.